CIK 0001420720
- Non-accelerated filer
- Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262797813
- Phone
- +1 302-355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- 4 Grant or award Chief Financial Officer acquired 37,500 shares (grant or award)
- 4 Open-market sale Brenner Martin sold 5,213 shares at $2.13 ($11,112)
- 4 Open-market sale Brenner Martin sold 3,976 shares at $1.77 ($7,038)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Interim CEO and CSO acquired 130,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 95,348 shares (grant or award)
- 4 Grant or award Lutz Robert Matthew acquired 100,057 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Lutz Robert Matthew sold 24,625 shares at $0.35 ($8,510)
- 4 Open-market sale Chief Operating Officer sold 37,243 shares at $0.68 ($25,444)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Insider Changes in Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 13 · 260 filings